Corindus Vascular Robotics (CVRS) Inventory Turnover Ratio, from second quarter 2019 to second quarter 2018, current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 
Corindus Vascular Robotics, Inc.  (CVRS)
 

Corindus Vascular Robotics Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Corindus Vascular Robotics, Inc. inventory turnover ratio, the Corindus Vascular Robotics, Inc.'s ability to sell and replace its inventory in the second quarter 2019, sequentially increased to 4.42 in the second quarter 2019, a new company high. Average inventory processing period, for the Corindus Vascular Robotics in Jun 30 2019 quarter, has decreased to 83 days, compare to 98 days, in the Mar 31 2019 quarter.

Within Healthcare sector 112 other companies have achieved higher inventory turnover ratio. While Inventory turnover ratio total ranking has improved so far during the II Quarter 2019, to 1195, from total ranking in the first quarter 2019 at 1353.

CVRS Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Corindus Vascular Robotics, Inc. Market Share?

What is Inventory Turnover Ratio?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

CVRS Inventory Turnover Ratio (Jun 30 2019)
II. Quarter		 (Mar 31 2019)
I. Quarter		 (Dec 31 2018)
IV. Quarter		 (Sep 30 2018)
III. Quarter		 (Jun 30 2018)
II. Quarter
Y / Y Inventory Growth -35.77 % -38.62 % 19.26 % -3.26 % 6.38 %
Y / Y Cost of Sales Growth 29.15 % 25.14 % -7.73 % -15.99 % -2.23 %
Inventory Turnover Ratio (TTM) 4.42 3.72 3.15 3.35 3.46
CVRS's Total Ranking # 1195 # 1353 # 1518 # 1600 # 1194
Average inventory processing period 83 98 116 109 106
Seq. Inventory Growth -3.59 % -25.6 % -6.21 % -4.53 % -7.86 %
Seq. Cost of Sales Growth 15.08 % -12.5 % 50.44 % -14.74 % 11.51 %




Inventory Turnover Ratio Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 37
Healthcare Sector # 113
Overall Market # 1195

Inventory Turnover Ratio Statistics
High Average Low
4.42 3.23 2.43
(Jun 30 2019)   (Dec 31 2015)



CVRS Company Profile >> Back to CVRS Efficiency Comparisons >> Compare CVRS Inventory Turnover Ratio to its Competitors

Financial Statements
Corindus Vascular Robotics's Inventories $ 2 Millions Visit CVRS's Balance sheet
Corindus Vascular Robotics's Cost of Revenues TTM $ 10 Millions Visit CVRS's Income Statement
What are CVRS's Sales? Visit CVRS's Sales by Segment

Other Inventory Turnover Ratios
Corindus Vascular Robotics's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Medical Equipment & Supplies Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
CVRS's Inventory Turnover Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for CVRS's Competitors
Inventory Turnover Ratio for CVRS's Suppliers
Inventory Turnover Ratio for CVRS's Customers

You may also want to know
CVRS's Sales Growth Rates CVRS's Pe Price to earnings ratio CVRS's Receivables Turnover Ratio CVRS's Stock Quote
CVRS's Net Income Growth Rates CVRS's Ps Price to Sales ratio CVRS's Sales per Employee CVRS's Asset Turnover Ratio
CVRS's Net Margin CVRS's Pb Price to Book ratio CVRS's Financial Strength Ratios CVRS's Dividend Payout Ratio



Companies with similar Inventory Turnover Ratio for the quarter ending Jun 30 2019, within Healthcare Sector Inventory Turnover Ratio Cost of revenues at quarter ending Jun 30 2019 Inventories at quarter ending Jun 30 2019
Star Equity Holdings Inc   14.95 $ 84.263  Millions$ 6  Millions
Rockwell Medical inc   14.17 $ 59.035  Millions$ 4  Millions
Aclaris Therapeutics Inc   14.16 $ 10.182  Millions$ 1  Millions
Puma Biotechnology Inc   12.93 $ 36.709  Millions$ 3  Millions
Ionis Pharmaceuticals Inc   12.86 $ 149.620  Millions$ 12  Millions
Natera Inc   11.87 $ 162.809  Millions$ 14  Millions
Amarin Corp Plcuk  11.70 $ 70.959  Millions$ 6  Millions
Infusystem Holdings Inc  11.02 $ 26.267  Millions$ 2  Millions
Fortress Biotech Inc   10.70 $ 7.255  Millions$ 1  Millions
Fonar Corporation  10.56 $ 18.257  Millions$ 2  Millions
Charles River Laboratories International inc   9.78 $ 1,266.428  Millions$ 130  Millions
Aeon Global Health Corp.  9.66 $ 4.696  Millions$ 0  Millions
Align Technology inc   9.44 $ 599.715  Millions$ 64  Millions
Veracyte Inc   8.71 $ 34.255  Millions$ 4  Millions
Vericel Corporation  8.58 $ 34.429  Millions$ 4  Millions
Nanomix Corp  8.57 $ 0.037  Millions$ 0  Millions
Orgenesis Inc   8.55 $ 16.264  Millions$ 2  Millions
Motus Gi Holdings Inc   8.36 $ 0.579  Millions$ 0  Millions
Perspective Therapeutics Inc   8.35 $ 4.267  Millions$ 1  Millions
H cyte Inc  8.35 $ 1.245  Millions$ 0  Millions
Advanced Container Technologies Inc   7.82 $ 1.391  Millions$ 0  Millions
Enzo Biochem Inc  7.59 $ 57.922  Millions$ 8  Millions
Avalo Therapeutics Inc   7.59 $ 7.281  Millions$ 1  Millions
Global Cord Blood Corp  7.56 $ 34.479  Millions$ 5  Millions
Ufp Technologies Inc   7.45 $ 145.227  Millions$ 19  Millions
Harrow Inc   7.41 $ 17.416  Millions$ 2  Millions
Zynex inc   7.34 $ 7.204  Millions$ 1  Millions
Musclepharm Corporation  7.33 $ 72.076  Millions$ 10  Millions
Horizon Therapeutics Public Limited Company  7.26 $ 374.915  Millions$ 52  Millions
Wearable Health Solutions, Inc.  7.23 $ 0.539  Millions$ 0  Millions

Date modified: 2026-09-08T15:09:39+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.